Pharmafile Logo

Wales’ New Treatments Fund

- PMLiVE

NICE launches consultation on its methods of drug evaluation

Public consultation launched on Friday 6 November

- PMLiVE

NHS gearing up for possible pre-Christmas COVID-19 vaccinations

NHS chief exec said the NHS is getting ready to administer vaccines

- PMLiVE

NICE – but not enough

Why evidence is better than assumption when executing commercial strategy

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Research Partnership

Case study

Using qualitative conjoint to assess willingness-to-pay

Research Partnership

- PMLiVE

NICE recommends Roche’s Polivy for B-cell lymphoma

Cost-effectiveness agency approves drug following initial rejection earlier this year

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

Research Partnership

- PMLiVE

NICE recommends Astellas’ Xospata for NHS use

Cost-effectiveness watchdog backtracks on previous rejection

- PMLiVE

AMICULUM® launches new specialist agency: AMICULUM Access

AMICULUM Access is a full-service market access agency bringing together existing in-house market access expertise from across AMICULUM’s agencies to provide a consolidated service to both new and existing clients.

AMICULUM

Mistura Informatics Pharmacist Donates Medicines Information Software to Tackle COVID-19

Mistura Informatics are donating their medicines information Software to the NHS for free to reduce pressure on NHS frontline staff during the COVID-19 crisis.

Onyx Health

- PMLiVE

NHS to set up hospital in ExCeL Centre as coronavirus cases grow

Over half a million people have also volunteered with the health service

- PMLiVE

NICE looks internally for new chief executive

Deputy chief exec Gillian Leng is set to take the helm

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links